Rather than interacting with immune cells, it is found that the expression of Gal-9 on the surface of tumor cells reduces the invasiveness of breast cancer cells by limiting their capacity to invade the surrounding extracellular matrix (ECM) and attach to the vascular endothelium [55]. This evidence concerns the gene LGALS9 and breast carcinoma.